ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.56B
Enterprise Value3.87B
P/E Ratio17.46
PEG Ratio0.86
Price/Sales Ratio1.63
Price/Book Ratio2.02
Enterprise/Revenue1.6
Enterprise/EBITDA11.02

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.09
Operating Margin0.13
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.12

Income Statement

Revenue3.63B
Revenue/Share7.59
Gross Profit3.63B
EBITDA514.55M
Net Income286.29M
Diluted EPS0.64

Balance Sheet

Total Cash707.98M
Total Cash/Share1.44
Total Debt564.3M
Total Debt/Equity0.19
Current Ratio1.45
Book Value Per Share6.92

Price History

52-Week Change19.23
52-Week High15.25
52-Week Low9.2
Moving Average 50 Days11.2
Moving Average 200 Days10.62

Statistics

Average Volume35.95M
Shares Outstanding492.21M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.38
Trailing Annual Dividend Yield3.06
Payout Ratio0.01
Last Split Factor6:5
Last Split DateJune 15, 2018
AD